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Protein–protein interactions of the p24 (HIV-1) capsid protein play an essential role in the production of infectious virus
particles. To map the putative p24 dimerization site, a set of overlapping peptides spanning the p24 sequence was prepared
using spot synthesis on a cellulose membrane and probed with recombinant p24 (rp24). Three sequence regions interacting
with rp24 were identified. Peptides from each region were synthesized, but only one peptide was effectively able to inhibit
rp24 dimerization in solution. Amino acids that were exposed in the corresponding p24 region were mutated in rp24, resulting
in a significant decrease of rp24 dimerization. Thus, participation of this region in virus capsid assembly can be assumed.
© 1999 Academic Press
Key Words: p24; HIV-1 capsid protein; dimerization; peptide scan; peptide/protein interaction; spot synthesis; substitutional
analysis.
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cAdvancement in the treatment of HIV-1 infection using
riple-drug combinations to inhibit reverse transcriptase
nd viral protease has led to dramatic reductions in the
iral load in infected individuals (1, 2). But problems with
omplications arising from drug resistance as a conse-
uence of the high mutation rates of HIV remain un-
olved thus far (3). The understanding of different steps
n the viral life cycle, namely capsid assembly and virus
article maturation, could add another weapon to the line
f attack.
About 1200 molecules of the capsid protein p24 of the
ature HIV form the inner shell around the viral RNA
oad (4). Thus, p24 interactions with itself and with neigh-
oring structural proteins certainly play a crucial role in
apsid assembly and the maturation steps leading to
nfectious particles, both during and after budding from
he cell membrane (5–7). Although published data have
hown that p24 forms dimers in solution (7, 8), their
iological role is not understood yet and it remains un-
lear whether these dimers represent a primary step in
apsid formation.
So far, four partial structures for p24 (HIV-1) have been
ublished: three comprising the N-terminal domain (AS
-151) and one the C-terminal domain (AS 146-231) (9–
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62). Three of these structures show intermolecular con-
act areas, but in different regions. It remains an open
uestion as to which of these regions represent the
ontact area used by p24 to dimerize or oligomerize
uring the assembly process and which are simply a
roduct of the crystallographic symmetry between mol-
cules.
Here we report the identification of a putative p24
imerization site by probing a p24 sequence-derived set
f overlapping peptides bound to a continuous cellulose
embrane support. The peptides identified as interact-
ng with a recombinantly expressed p24 protein (rp24;
13)) were synthesized in solution and tested for their
bility to suppress rp24 dimerization in solution by
eans of analytical ultracentrifugation. Furthermore, ex-
osed residues in a p24 region corresponding to peptide
(IPVGEIYKRW) were mutated to prove participation in
he dimerization process.
The dissociation constant for the monomer/dimer
quilibrium of p24 is reported to be 5.4 to 39 mM at pH
alues between 4 and 8 as derived from analytical affinity
hromatography or 13 mM at pH 5 from ultracentrifuge
xperiments (8). Because our rp24 sequence deviates
lightly from wild-type p24 at the N-terminus, we deter-
ined the monomer/dimer equilibrium constant for rp24
t pH 6.0 and 10°C by analytical affinity chromatography
s described by Rose´ et al. (8). The resulting dissociation
onstant (KM/P) value of 11 mM is on the same order of
agnitude as that reported by Rose´ et al. Therefore, the
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7RAPID COMMUNICATION-terminal sequence (here MNSAM. . . instead of PI. . .)
eems to have little influence on the monomer/dimer
issociation constant, suggesting that the proline at se-
uence position 1 of wild-type p24 that forms a salt
ridge with D-51 in the mature p24 structure (9) plays no
ignificant role in its dimerization behavior.
To locate linear sequence parts of the discontinuous
imerization site involved in the interaction between rp24
onomers we used spot synthesis to generate a peptide
can of overlapping p24-derived peptides (13mers with a
0-amino-acid overlap). The cellulose-bound peptides
ere screened for p24 binding by incubation with recom-
inant p24 (rp24). Bound protein was subsequently
ransferred by electroblotting onto a PVDF membrane.
his facilitated the detection of bound rp24 even in the
ase of comparatively low affinities by conventional im-
unoblotting techniques using a murine anti-p24 mono-
lonal antibody and avoided interference of the antibody
ith membrane-bound peptides. A blot of the probed
eptide scan, together with the corresponding densito-
etric analysis and sequences of the relevant peptides,
s presented in Fig. 1. Three clearly defined sequence
egions showed significant interactions with rp24: a re-
FIG. 1. Interaction of rp24 with p24-derived overlapping peptides as
isualized after blotting. (Top) The numbers left and right of the panel
efer to the ordering of the peptide spots on the cellulose membrane
sed in the rp24 binding step. (Middle) Relative intensities of the
lotted rp24 dots as measured by densitometry of the immunoblot.
Bottom) Sequences of the corresponding peptides from the identified,
umbered positions and area of the peak determined by densitometry
f the immunoblot. To omit the background of the blot for clarity the
omputer program “Corel Photo-Paint” version 6.00.103 (Corel Corp.)
as used.ion comprising the peptides 54–57 (p24 residues 157 to t78) with the strongest interaction, peptides 47–49 (p24
esidues 136 to 154) with somewhat weaker binding, and
eptides 42 and 43 (p24 residues 121 to 136) with the
eakest signal.
To decide whether the sequence regions that bind
p24 are involved in p24 dimerization, represent addi-
ional potential contact sites involved during capsid as-
embly, or simply mediate nonspecific interactions, free
eptides selected from those regions were used to mon-
tor their influence on p24 dimerization in solution. In
ddition, peptides derived from putative p24 interaction
ites described in the literature were included in the
nalysis. The following peptides were chosen: peptide 1
IPVGEIYKRW; sequence position 124–133) derived from
egion 1 of the peptide scan; peptide 2 (VRMYSPTS;
equence position 142–149) from region 2; and peptide 3
PFRDYVDRFYKTL; sequence position 160–172) from re-
ion 3. The length of these peptides was based on the
inding profile of rp24 to the various overlapping se-
uences, but neighboring hydrophobic residues, which
ould reduce the peptide solubility, were omitted. In
ddition, peptide 4 (PAATLEEMMTA; sequence position
07–217) from the p24 C-terminal domain, which was
eported to inhibit HIV virus spread in cell cultures (14),
nd three peptides from the putative dimerization sites
erived from X-ray structures were included. These three
dditional peptides are peptide 5 (DIAGTTSTLQEQ; po-
ition 103–114 in p24 N-terminal domain) (12); peptide 6
AFSPEVIPMFSAL; position 31–43) (10); and peptide 7
QEVKNWMTETLL; position 179–190) (11).
Analytical ultracentrifugation was used to investigate
he influence of peptides on the monomer/dimer equilib-
ium of rp24 in solution. An intermediate concentration of
he protein was chosen for all experiments (about 8 mM).
he apparent average molecular mass of rp24 in the
bsence of peptides was calculated to be between 40
nd 42 kDa at this concentration. Peptides were added
p to a 35-fold molar excess over the rp24 concentration
efore ultracentrifugation. From the sedimentation equi-
ibrium measurements the weight average molecular
ass (Mw) of rp24 was calculated. The results are shown
n Fig. 2. Peptides 2 to 7 had no significant effect on the
w values of rp24. Since preliminary experiments with
eptide 1 indicated a clear influence on the sedimenta-
ion behavior of rp24, more detailed analyses were per-
ormed testing various concentrations of this peptide.
rom the concentration-dependent influence of peptide 1
n the monomer/dimer ratio of rp24 and taking into
ccount the equilibrium constant of this process, a dis-
ociation constant of 3.7 6 0.1 3 1025 M was calculated
or the interaction of peptide 1 with rp24.
Suppression of p24 dimerization by a sequence-de-
ived peptide does not necessarily mean that this se-
uence region is involved in the dimerization site. There-
ore, mutations were introduced into rp24 to ascertain
he importance of such a site. From an inspection of the
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8 RAPID COMMUNICATIONegion corresponding to peptide 1 in the p24 N-terminal
omain structure, there are mainly two residues that are
andidates for being involved in p24–p24 interaction:
128 and R132. In our study E128 was mutated to alanine
rp24/E128A) or arginine (rp24/E128R), and R132 was
utated to glutamate (rp24/R132E).
In the ultracentrifugation experiments the first two mu-
ants show a significantly lower tendency for dimeriza-
ion, with the dimerization constant differing by a factor of
bout 4–5 for the E128A mutant (Fig. 3) and of about 2 for
he E128R mutant in comparison with the constant for
ild-type rp24 (data not shown). The third mutation,
132E with R132, had no influence on the rp24 dimeriza-
ion behavior (Fig. 3). There were no differences between
he CD spectra of the wild-type rp24 and refolded mutant
roteins (data not shown). Their stability toward GuHCl
enaturation as measured by the shift in fluorescence
mission spectra was slightly lower than that of the
ild-type rp24 (data not shown).
Analyses of overlapping peptides spanning the entire
24 sequence revealed three different p24 regions bind-
ng to the recombinant p24 protein. All three regions
ontain a number of highly conserved positions when
equences from different HIV-1, HIV-2, and SIV isolates
re compared. For instance, region 3 comprises a se-
uence with conserved positions accumulated in all ret-
oviral gag genes, the so-called “major homology region”
MHR, positions 153 to 173 in the p24 sequence (15)).
The region represented by peptide 1 (sequence posi-
ion 124 to 133) is part of helix VII in the N-terminal
FIG. 2. Influence of peptides on rp24 dimer formation. The apparent
olecular weight of rp24 in the presence of varying concentrations of
ifferent peptides was measured by sedimentation equilibrium centrif-
gation. The indicated dimer and monomer limits were derived from the
heoretical molecular weights. (n) Peptide 1 (IPVGEIYKRW); (h) peptide
(VRMYSPTS); () peptide 3 (PFRDYVDRFYKTL); (E) peptide 4 (PAATL-
EMMTA); () peptide 5 (DIAGTTSTLQEQ); (p) peptide 6 (AFSPEVIPMF-
AL); (1) peptide 7 (QEVKMWMTETLL).omain of the p24 structure (9). In addition, it has been mhown by Niedrig et al. (14) that a peptide from this
egion is able to inhibit the virus spreading in cell culture,
lbeit less effectively than the peptide from the C-termi-
al part of p24, which was also included in the experi-
ents described here (peptide 4). Results of an amino
cid deletion at positions 132 to 136, overlapping with the
ast two residues of peptide 1, revealed a reduced virus
eplication, but the mutant particles are able to assemble
nd can release viral particles. It was shown that the
orphology of the particle is changed (16).
In recent reports on partial p24 structures solved by
-ray analysis (N-terminal domain, (10, 12); C-terminal
omain, (11)) there are four different proposed dimeriza-
ion sites (Fig. 4). For the complex between anti-p24 Fab
ragment and p24 (12) the sequence region correspond-
ng to peptide 1 does not fit the interface region between
wo p24 molecules in the crystal structure. Two interface
egions (p24 positions 18 to 29/30 to 45 and positions
32 to 143) are depicted by X-ray structure analysis of the
yclophilin A/N-terminal p24 fragment complex (10). The
egion corresponding to p24 sequence positions 132 to
43 lies exactly between our peptide 1 and 2 sequences
nd overlaps at both ends by two amino acids each (p24
ositions 132/133 and 142/143). This means that at least
he sequence region of peptide 1 with its inhibitory effect
n rp24 dimerization lies in the vicinity of a crystallo-
raphically detected p24–p24 interface. All other pep-
ides derived from putative dimerization sites (peptides 5,
, and 7) had no influence on the p24 dimerization be-
avior. Certainly not all the interface regions derived from
he crystal structures need be involved in the dimeriza-
ion process in solution or the capsid assembly in vivo;
hey may simply be a result of crystal packing. Only for
he interface region of the C-terminus was it shown that
FIG. 3. Concentration dependence of dimer formation for wild-type
p24 and mutants as measured by analytical ultracentrifugation. (F)
ild-type rp24; (n) E128A mutant; () R132E mutant. The bars indicate
he variation of values as calculated from different points of measure-ent within one experiment.
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9RAPID COMMUNICATIONutations introduced within the putative interaction re-
ion abolished the dimerization of the complete p24 at
oncentrations up to 0.25 mg/ml (11). Our analytical ul-
racentrifugation data with a M184A mutant clearly
howed the occurrence of dimers at concentrations
igher than 1 mg/ml. That the peptide derived from this
egion (peptide 7) does not influence the dimerization
ehavior of p24 may be due to a low affinity of the
eptide for p24. This may also hold true for peptides
erived from other regions except that of peptide 1.
Inspection of the sequence region corresponding to
eptide 1 in the p24 structure led to the identification of
wo potential key residues of interaction: both E128 (po-
ition 5 in peptide 1) and R132 (position 9 in peptide 1)
re solvent exposed. But only the E128A and E128R
utants of rp24 show diminished dimerization tendency
ithout any detectable influence on the overall p24 fold-
ng as judged by CD. Therefore, this residue seems to be
FIG. 4. Schematic representation of the structure of the N- and C-term
f the Brookhaven Protein Structure Data Base). The location of peptide
ites as derived from the X-ray structures are indicated in blue. (A) From
omplex (10); (D) from the C-terminal domain (11).f special importance in p24 intermolecular contacts in mddition to the role of the C-terminal domain described in
he literature (11).
Derivatives of peptide 1 are currently being tested in
ell cultures to investigate their inhibitory effect on HIV
irus spreading. Furthermore, a p24 double-mutant con-
aining substitutions in the sequence region correspond-
ng to peptide 1 and peptide 7 is under construction to
uppress dimerization even at high protein concentra-
ions necessary for crystallization experiments or NMR
tudies with the complete protein.
Mutations were introduced using Chameleon Double-
tranded Site-Directed Mutagenesis Kit (Stratagene, La
olla) according to the manufacturer’s protocol except that
he temperature was kept at 28°C. All details about the
ector construction, as well as the expression and purifica-
ion procedure, were described by Hausdorf et al. (13).
Peptide scans were automatically synthesized
Abimed, Lengenfeld) as previously described (17). The
mains of p24 as derived from X-ray data (files 1AK4.pdb and 1AM3.pdb
own in yellow with the glutamate 128 highlighted. Putative dimerization
b/p24 complex (12); (B) and (C) from the N-terminal domain/cyclophilininal do
1 is sh
the Faembranes were blocked by incubation with a solution
o
c
a
i
i
T
m
n
3
t
m
5
m
s
g
D
D
a
p
F
c
r
r
1
t
p
r
a
r
b
t
t
o
r
b
m
c
w
b
m
r
a
D
1
1
1
1
1
1
1
1
1
10 RAPID COMMUNICATIONf 3% dry milk powder in Tris-buffered saline, pH 7.5,
ontaining 1% Tween 20 (TTBS) for 2 h at room temper-
ture, washed three times with TTBS for 5 min each, and
ncubated for 3 h at room temperature with 75 mg/ml rp24
n 50 mM citrate buffer, pH 6.0, containing 0.15 M NaCl.
he membranes were finally washed with TTBS for 4
in. The bound protein was electroblotted to a polyvi-
ylidene difluoride (PVDF) membrane at 0.8 mA/cm2 for
0 min. The PVDF membranes were blocked by incuba-
ion with a solution of 3% dry milk powder in TTBS for 30
in and subsequently washed three times with TTBS for
min each. Bound rp24 was detected using the murine
onoclonal anti-p24 antibody CB4-1 (2 mg/ml) and a
heep anti-mouse IgG horseradish peroxidase conju-
ate (Amersham, Freiburg) (dilution 1:1000). 3,39-
iaminobenzidine tetrahydrochloride (0.8 mg/ml) (Sigma,
eisenhofen) in 100 mM Tris–HCl, pH 7.5, with 0.2% NiCl2
nd 0.03% H2O2 was used as the peroxidase substrate.
Standard protocols were used for the covalent cou-
ling of rp24 (11 mg) to BrCN–Sepharose (Pharmacia,
reiburg) (0.7 g) in 0.5 M sodium bicarbonate buffer
ontaining 0.5 M NaCl at pH 8.0. Zonal elution profiles for
p24 at room temperature were obtained by injecting
p24 samples (200 ml) at concentrations between 50 and
mM at a flow rate of 0.25 ml/min. The determination of
he dissociation constant for the dimeric complex was
erformed as described by Rose´ et al. (8).
Sedimentation equilibrium measurements were car-
ied out using a Beckman XL-A ultracentrifuge with UV
bsorbance optics and six-channel cells. About 70 ml of
p24 at a concentration of about 8 mM in 50 mM citrate
uffer, pH 6.0, containing 0.15 M NaCl was aliquoted in
he absence or in the presence of different amounts of
he appropriate peptide into the different compartments
f the six-channel cells and centrifuged for 2 h at 30,000
pm to accelerate the concentration distribution followed
y an equilibrium speed of 24,000 rpm for 22–24 h. All
easurements were carried out at 10°C. The radial con-
entration distributions at the sedimentation equilibrium
ere recorded by measuring the absorption against
uffer at 280, 285, and 290 nm. Using the program “Poly-
ole” (18), the weight average molecular mass Mw of
p24 was calculated.
ACKNOWLEDGMENTS
The authors thank Helga Wessner and Dina Reinhardt for technical
ssistance. The work was partly supported by Grant Ho 1377/7-1 of the
eutsche Forschungsgemeinschaft.
REFERENCES
1. Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupan-
cic, M., Gebhardt, K., Henry, K., Zhang, Z., Mills, R., McDade, H.,Goudsmit, J., Danner, S. A., and Haase, A. T. (1997). Kinetics of
response in lymphoid tissues to antiretroviral therapy of HIV-1
infection. Science 276, 960–963.
2. Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A.,
Saksella, K., Markowitz, M., and Ho, D. D. (1997). Decay char-
acteristics of HIV-1-infected compartments during combination
therapy. Nature 387, 188–191.
3. Cohen, J. (1997). The daunting challenge of keeping HIV sup-
pressed. Science 277, 32–33.
4. Hong, S. S., and Boulanger, P. (1993). Assembly-defective point
mutants of the human immunodeficiency virus type 1 Gag pre-
cursor phenotypically expressed in recombinant baculovirus-
infected cells. J. Virol. 67, 2787–2798.
5. Gottlinger, H. G., Sodroski, J. G., and Haseltine, W. A. (1989). Role of
capsid precursor processing and myristoylation in morphogen-
esis and infectivity of human immunodeficiency virus type 1.
Proc. Natl. Acad. Sci. USA 86, 5781–5785.
6. Gelderblom, H. R. (1991). Assembly and morphology of HIV, poten-
tial effect of structure on viral function. AIDS 5, 617–637.
7. Ehrlich, L. S., Agresta, B. E., and Carter, C. A. (1992). Assembly of
recombinant human immunodeficiency virus type 1 capsid pro-
tein in vitro. J. Virol. 66, 4874–4883.
8. Rose´, S., Hensley, P., O’Shannessy, D. J., Culp, J., Debouck, C., and
Chaiken, I. (1992). Characterization of HIV-1 p24 self-association
using analytical affinity chromatography. Proteins 13, 112–119.
9. Gitti, R. K., Lee, B. M., Walker, J., Summers, M. F., Yoo, S., and
Sundquist, W. I. (1996). Structure of the amino-terminal core
domain of the HIV-1 capsid protein. Science 273, 231–235.
0. Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart,
M., Sundquist, W. I., and Hill, C. P. (1996). Crystal structure of
human cyclophilin A bound to the amino-terminal domain of
HIV-1 capsid. Cell 87, 1285–1294.
1. Gamble, T. R., Yoo, S., Vajdos, F. F., von Schwedler, U. K., Worthylake,
D. K., Wang, H., McCutcheon, J. P., Sundquist, W. I., and Hill, C. P.
(1997). Structure of the carboxyl-terminal dimerization domain of
the HIV-1 capsid protein. Science 278, 849–853.
2. Momany, C., Kovari, L. C., Prongay, A. J., Keller, W., Gitti, R. K., Lee,
B. M., Gorbalenya, A. E., Tong, L., McClure, J., Ehrlich, L. S.,
Summers, M. F., Carter, C., and Rossmann, M. G. (1996). Crystal
structure of dimeric HIV-1 capsid protein. Nature Struct. Biol. 3,
763–770.
3. Hausdorf, G., Gewiess, A., Wray, V., and Porstmann, T. (1994). A
recombinant human immunodeficiency virus type-1 capsid pro-
tein (rp24): its expression, purification and physico-chemical
characterization. J. Virol. Methods 50, 1–9.
4. Niedrig, M., Gelderblom, H. R., Pauli, G., Marz, J., Bickhard, H., Wolf,
H., and Modrow, S. (1994). Inhibition of infectious human immu-
nodeficiency virus type 1 particle formation by Gag protein-
derived peptides. J. Gen. Virol. 75, 1469–1474.
5. Wills, J. W., and Craven, R. C. (1991). Form, function, and use of
retroviral gag proteins. AIDS 5, 639–654.
6. Dorfman, T., Bukovsky, A., Ohagen, A., Hoglund, S., and Gottlinger,
H. G. (1994). Functional domains of the capsid protein of human
immunodeficiency virus type 1. J. Virol. 68, 8180–8187.
7. Kramer, A., and Schneider-Mergener, J. (1998). Synthesis of peptide
libraries on continuous cellulose membranes. Methods Mol.
Biol. 87, 25–39.
8. Behlke, J., Ristau, O., and Marg, A. (1995). Complex formation and
crystallisation of adrenodoxin-reductase with adrenodoxin.
Prog. Colloid Polym. Sci. 99, 63–68.
